ethyl 4-(5-amino-1-methylbenzimidazol-2-yl)butanoate

We are ethyl 4-(5-amino-1-methylbenzimidazol-2-yl)butanoate CAS:3543-73-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  ethyl 4-(5-amino-1-methylbenzimidazol-2-yl)butanoate
CAS.NO:3543-73-5
Synonyms:
1H-benzimidazol-1-methyl-5-amino-2-butanoic acid ethyl ester
5-amino-1-methyl-2-Benzimidazolebutyric acid ethyl ester
4-(5-amino-1-methyl-1H-benzoimidazol-2-yl)-butyric acid ethyl ester
Ethyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate
ethyl-4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl) butanoate
5-Amino-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester
1-Methyl-5-amino-1H-benzimidazole-2-butanoicacidethylester
ethyl 4-(5-amino-1-methyl-1H-benzimidazol-2-yl)butanoate

Molecular Formula:C14H19N3O2
Molecular Weight:261.32000

Physical and Chemical Properties:
Density: 1.21 g / cm3
Boiling point: 471.6ºC at 760 mmHg
Melting point: 130-135ºC
Flash point: 239ºC
Refractive index: 1.59

Specification:
Appearance:  Brown powder
Purity:≥99%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Bendamustine hydrochloride CAS:3543-75-7
Intermediates of Bendamustine CAS:16506-27-7

Related News: As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured.38428-14-7 With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.95-70-5 With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.2-Chloro-4-fluorotoluene Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.